Many oral hypoglycaemic agents, such as sulfonylurea and biguanides, are available along with insulin for the treatment of diabetes mellitus, but these agents have significant side effects [3], and some are ineffective in chronic diabetic patients [4]. This evidence concerns the gene INS and diabetes mellitus.